[Tumor vaccines and active specific immunotherapy].
Schirrmacher
V
V
Deutsches Krebsforschungszentrum, Heidelberg.
D000818:Animals; D018033:Antibodies, Bispecific / Q000276:immunology / Q000627:therapeutic use; D000951:Antigens, Neoplasm / Q000276:immunology; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D008213:Lymphocyte Activation / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology; D016896:Treatment Outcome
D018033:Antibodies, Bispecific; D000951:Antigens, Neoplasm
Tumorvakzine und aktiv spezifische Immuntherapie.